Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Resphera Biosciences is a private U.S. life science analytics company focused on computational and biostatistical analysis services for translational research. The company supports microbiome, cancer genomics, and broader biostatistics workflows, including 16S rRNA amplicon analysis, shotgun metagenomics, metatranscriptomics, whole-exome analysis, ctDNA profiling, biomarker discovery, and multi-omics integration. Rather than developing therapeutic drugs, Resphera operates as a specialized research and data-analysis partner for medicine and biotechnology organizations. The company also owns First Look Data, an automated statistical analysis platform intended to help researchers generate insights from complex datasets. Overall, Resphera appears to function as a niche healthcare-focused analytics and bioinformatics provider serving research, translational, and clinical-study use cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Resphera Biosciences.